Of note, treatment with imatinib exhibited a reduced amount of pathogenic IL-4-producing T cells in bronchoalveolar lavage of SSc patients, which was accompanied by elevated numbers of total T helper cells. The gene discussed is IL4; the disease is systemic sclerosis.